EDMONTON, Alberta (AP) — EDMONTON, Alberta (AP) — Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported second-quarter net income of $37.4 million.
The Edmonton, Alberta-based company said it had net income of 28 cents per share.
The biotechnology company posted revenue of $83.2 million in the period.
Aurinia shares have dropped almost 5% since the beginning of the year. The stock has risen 30% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AUPH at https://www.zacks.com/ap/AUPH
/Netflix%20open%20on%20tablet%20by%20rswebsols%20via%20Pixabay.jpg)